Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

The Pathologist / App Notes / 2021 / Biomarker Optimization on LabSat® Research

Biomarker Optimization on LabSat® Research

03/23/2021

Share

 

Biomarker discovery research in the field of immuno-oncology relies heavily on immunohistochemistry (IHC) assays, involving the execution of tailored protocols with a high number of steps, all of which are subject to optimization. This can be a lengthy process that can take days, weeks and even months to perform, and requires a step-by-step approach to finetune protocol conditions such as assay temperature, antibody concentration or incubation times, in order to achieve optimal results with minimal investment ofresources. Turnaroundtimes of manual assays, even for single marker stainings, often require overnight incubations, and existing automated staining platforms, while faster, still require several hours to stain one marker and can appear to be very expensive when performed for high throughput, which turns these optimization phases into a long burdensome processes.

 

 

The LabSat® Research platform is an automated tissue immunostainer device. The system is pressurized and provides precise temperature and reagent flow control in order to finetune and optimize conditions, allowing high-quality and fast multiplexing of up to 6 markers within a few hours, and can perform single-plex staining under 30 minutes. This short timeframe is particularly well suited to run fast protocols during assay optimization in just a few samples, instead of staining large batches of slides to save precious samples or reagents.

 

 

>> Download the Application Note as a PDF

 

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Fast and automated TSA-based multiplexed immunofluorescence on LabSat® Research

February 15, 2021

A single NGS workflow for comprehensive genomic profiling

February 23, 2021

Biomarker Optimization on LabSat® Research

March 23, 2021

Fully automated quantification of Meropenem, Tazobactam, Piperacillin and Dexamethasone in plasma

May 4, 2021

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.